Skip to main content
. 2021 Dec 6;9(34):10595–10603. doi: 10.12998/wjcc.v9.i34.10595

Table 6.

Comparison of the adverse reactions between the two groups, n (%)

Groups
n
Nausea
Emesis
Hypotension
Drowsiness
Uroschesis
Incidence of adverse reactions
Remimazolam group 40 1 0 1 1 1 4 (10.00)
Propofol group 40 3 1 3 3 2 12 (30.00)
χ 2 value 5.000
P value 0.025